| Name |
Megace 160 mg tablete |
| Marketing Authorisation Number |
HR-H-977775077 |
| Active Substance |
megestrolacetat |
| Composition |
jedna tableta sadrži 160 mg megestrolacetata |
| Pharmaceutical Form |
tableta |
| Manufacturer |
Haupt Pharma Amareg GmbH, Regensburg, Njemačka |
| Marketing Authorisation Holder |
Bausch Health Ireland Limited, 3013 Lake Drive, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date |
01.06.2020 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/15-02/419 |
| Registration Number |
381-12-01/30-20-25 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ograničeni recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
L02AB01 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
